Le traitement médicamenteux de la sclérose en plaques en Thaïlande coûte généralement entre $3,000 / 111,000฿ et $6,000 / 222,000฿. Le tarif dépend de la classe du médicament, du niveau de la clinique et de la ville. En France, ces soins coûtent en moyenne $5,000 / 185,000฿. La Thaïlande permet une économie d'environ 40%. Le coût standard inclut la consultation initiale, les analyses de base et le traitement lui-même.
Avis d'expert Bookimed : Choisir un établissement accrédité JCI comme l'hôpital Bumrungrad garantit l'accès à une neurologie de pointe. Malgré les marges des hôpitaux privés, les patients profitent d'outils comme l'imagerie assistée par intelligence artificielle. Pour les solutions régénératrices, les cliniques de Phuket proposent des cultures cellulaires reconnues par le NLEM. Cette offre combine traitements biologiques avancés et soins de support à un tarif avantageux par rapport à l'Occident.
| Thaïlande | Turquie | Espagne | |
| Traitement médicamenteux de la sclérose en plaques | de $3,000 / 111,000฿ | de $2,500 / 92,500฿ | de $3,000 / 111,000฿ |
| Ocrevus (ocrélizumab) | de $20,000 / 740,000฿ | de $10,000 / 370,000฿ | de $25,000 / 925,000฿ |
Bookimed ne facture pas de frais supplémentaires pour les prix des Traitement médicamenteux de la sclérose en plaques. Les tarifs sont issus des listes de prix officielles des cliniques. Vous payez directement à la clinique lors de votre arrivée pour votre Traitement médicamenteux de la sclérose en plaques.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans Traitement médicamenteux de la sclérose en plaques et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de Traitement médicamenteux de la sclérose en plaques.
Dr. Siriporn Cheawchanwej is an aesthetic and anti-aging physician. She holds a Diploma in Aesthetic Medicine from the American Academy of Aesthetic Medicine and completed advanced training at the School of Anti-Aging and Regenerative Medicine and in Facial Design at Mae Fah Luang University.
Her international training includes Restylane seminars in Sweden (2006–2008) and the International Symposium of Botulinum Toxin in Korea. She also attended the Asia Pacific Rhinoplasty Expert Forum in Seoul, the International Congress of Minimal Invasive Plastic Surgery & Dermatology in Seoul, and IMCAS Asia 2009.
Common multiple sclerosis medications in Thailand include disease-modifying therapies like Interferon beta-1a and fingolimod. Patients access high-efficacy infusions such as ocrelizumab and rituximab at major neurological centers. Private hospitals in Bangkok and Phuket provide oral options, injectables, and specialized supportive care like cannabis extracts for spasticity.
Bookimed Expert Insight: While top centers like Bumrungrad International Hospital offer the latest biologics, costs vary significantly by sourcing. Patients often save by using Indian generics for fingolimod. These can reduce monthly expenses to approximately 20,000 THB. Always confirm if your clinic allows pharmacy-sourced medications versus in-house stock.
Patient Consensus: Many patients find that while high-end drugs require long insurance approval wait times, generics from India are well-tolerated and more accessible. Navigating the import process through specialized pharmacies in Singapore is a common strategy for aggressive MS cases.
Multiple sclerosis symptoms like muscle stiffness, or spasticity, are effectively managed in Thailand through specialized medications and physical therapies. Modern neurological centers like Bumrungrad International Hospital utilize oral relaxants, Botox injections, and advanced cellular therapies to reduce painful spasms and improve patient mobility.
Bookimed Expert Insight: While many seek the latest biologics, Thailand differentiates itself through integrated regenerative approaches. Clinics like The Demarest Clinic use AABB-certified protocols and IV therapies alongside traditional meds. This combination often targets systemic inflammation rather than just suppressing isolated muscle symptoms.
Patient Consensus: Patients emphasize that skipping daily stretching makes stiffness dramatically worse. Many find that taking tizanidine at night provides the best relief for spasms without daytime drowsiness.
Patients receive specialized multiple sclerosis treatment in Thailand at JCI-accredited centers like Bumrungrad International Hospital and specialized regenerative clinics in Phuket. These facilities provide advanced diagnostics like 3T MRI, disease-modifying therapies, and innovative mesenchymal stem cell protocols for neuro-inflammation management.
Bookimed Expert Insight: While Thailand is famous for stem cells, its diagnostic infrastructure is the true highlight. Clinics like Bumrungrad serve over 500,000 international patients annually. This massive volume ensures neurologists see rare MS variants more frequently than many Western specialists. This experience often leads to more precise long-term medication adjustments.
Patient Consensus: Patients emphasize securing local prescriptions at Bangkok hospitals for easier medication imports. They recommend maintaining a telehealth link with home specialists to coordinate complex infusion schedules while abroad.
Stem cell therapy is a regulated option for MS in Thailand, primarily utilizing Mesenchymal Stem Cells (MSCs). While the Thai Food and Drug Administration (TFDA) oversees these treatments, they are often used as supportive regenerative care alongside standard disease-modifying therapies in Bangkok and Phuket clinics.
Bookimed Expert Insight: While many private clinics focus on UC-MSC infusions, high-volume centers like Bumrungrad International Hospital serve 1,000,000 patients annually by integrating advanced neurology with regenerative options. Choosing a hospital with JCI and GHA credentials ensures international safety standards that smaller, boutique stem cell clinics may not provide.
Patient Consensus: Patients emphasize the need for transparency regarding long-term results and suggest consulting a home neurologist before traveling. Many recommend verifying if clinic claims are backed by entries in clinical trial registries or PubMed.